A citation-based method for searching scientific literature

Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M Ballantyne, Philip J Barter, Michael H Davidson, John J P Kastelein, Wolfgang Koenig, Darren K McGuire, Dariush Mozaffarian, Paul M Ridker, Kausik K Ray, Brian G Katona, Anders Himmelmann, Larrye E Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E Nissen. JAMA 2020
Times Cited: 261



Anders Berg Jørgensen, Ruth Frikke-Schmidt, Børge G Nordestgaard, Anne Tybjærg-Hansen. N Engl J Med 2014
Times Cited: 606




List of shared articles



Times cited

Working towards full eradication of lipid-driven cardiovascular risk?
N S Nurmohamed, E S G Stroes. Neth Heart J 2022
1

A Modern Approach to Dyslipidemia.
Amanda J Berberich, Robert A Hegele. Endocr Rev 2022
15

Addressing dyslipidemic risk beyond LDL-cholesterol.
Alan R Tall, David G Thomas, Ainara G Gonzalez-Cabodevilla, Ira J Goldberg. J Clin Invest 2022
12

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk.
Jean-Claude Tardif, Ewa Karwatowska-Prokopczuk, Eric St Amour, Christie M Ballantyne, Michael D Shapiro, Patrick M Moriarty, Seth J Baum, Eunju Hurh, Victoria J Bartlett, Joyce Kingsbury,[...]. Eur Heart J 2022
21

A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?
Natalie C Ward, Dick C Chan, Gerald F Watts. BioDrugs 2022
2

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia.
Jan Borén, Marja-Riitta Taskinen, Elias Björnson, Chris J Packard. Nat Rev Cardiol 2022
8

Approach to patients with hypertriglyceridemia.
Alan Chait, Kenneth R Feingold. Best Pract Res Clin Endocrinol Metab 2022
0

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.
Bai-Hui Zhang, Fan Yin, Ya-Nan Qiao, Shou-Dong Guo. Front Mol Biosci 2022
3

Safety and efficacy of therapies for chylomicronemia.
Isabel Shamsudeen, Robert A Hegele. Expert Rev Clin Pharmacol 2022
0